Age-specific oncogenic pathways in head and neck squamous cell carcinoma - are elderly a different subcategory?

Background In recent clinical practice, an increasing number of elderly patients suffering from head and neck squamous cell carcinoma (HNSCC) of unknown pathophysiology is observed. The majority of HNSCC patients can roughly be divided into three subcategories. First, a small group of young patients who present with variants of genomic aberrations and inheritable diseases like Fanconi anaemia. Second, an increasing population of HPV-related HNSCCs that are regarded as genomic stable tumours with a more favourable prognosis. Though HPV-related tumours used to be more common among younger males, a notable rise in the elderly population is observed. The third subcategory, that of HPV-negative tumours, has been shown to be more heterogeneous with involvement of a variety of oncogenic pathways related to lifestyle factors like smoking and alcohol consumption, often seen in middle-aged males. Some of these pathways could be related to age, such as TP53 alterations, EGFR activation, apoptotic pathway alterations and field cancerization. Conclusions In this narrative review, we provide an overview of established and newly discovered age-specific pathophysiological mechanisms underlying HNSCC. We propose a fourth subcategory of patients with a suspected different pathophysiology: elderly (HPV-negative) HNSCC patients without a history of tobacco and alcohol consumption. In this subcategory, carcinogenesis seems to be a multi-step process based on genomic instability, immunosenescence, cell cycle disruption and telomere shortening. To conclude, we discuss suggestions for future research to fill the knowledge gap about age-dependent HNSCC carcinogenesis.

Automated summary

In recent clinical practice, an increasing number of elderly patients with head and neck squamous cell carcinoma (HNSCC) of unknown pathophysiology is observed. HNSCC patients can be divided into three subcategories: young patients with genomic aberrations and inheritable diseases, HPV-related HNSCCs with a more favorable prognosis, and HPV-negative tumors involving lifestyle factors. The proposed fourth subcategory is elderly (HPV-negative) HNSCC patients without a history of tobacco and alcohol consumption, which may have different pathophysiological mechanisms. Future research is needed to fill the knowledge gap.